Navigation Links
Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects
Date:5/23/2013

(PRWEB) May 23, 2013

During pregnancy both the health of the mother and the growing fetus are affected by medical treatments, especially medication. In July 2006, a study published by the New England Journal of Medicine prompted the FDA to warn about a potential link between certain antidepressant drugs and serious birth defects such as persistent pulmonary hypertension and other malformations (i). The FDA specifically warned about selective serotonin reuptake inhibitor (SSRI) drugs. SSRI antidepressants are widely prescribed to treat conditions like anxiety, depression, and obsessive compulsive disorder. SSRI drugs include Celexa, Lexapro, Paxil, Prozac, and Zoloft. Prozac was the first on the market in 1987 and approval for other antidepressants followed shortly after.

Initially, the FDA was concerned about women who were pregnant or planning to become pregnant because the study published in the New England Journal of Medicine suggested that antidepressant use could pose a risk if taken during the early stages of pregnancy. The FDA’s concerns were validated by another study published in the same journal in June 2007. The study sampled 10,000 infants born with birth defects and approximately 6,000 healthy infants. Researchers found that women who took Zoloft (sertraline) in the early months of pregnancy had twice the risk of having a baby born with a heart defect. Additionally, women on Paxil (paroxetine) had over three times the risk (ii).

The FDA has since asked drug manufacturers like GlaxoSmithKline (GSK) to strengthen the warning of these antidepressants. According to a Bloomberg Report from July 2010, GSK has settled approximately 800 birth defect claims for an estimated $1 billion (iii). The antidepressant informational graphic describes this settlement as well as providing information on two medical studies. Find out more about the factors you should consider when taking antidepressants during pregnancy by visiting the antidepressant webpage and viewing the antidepressant infographic: Antidepressant Infographic.

If you or a loved one has taken antidepressants during pregnancy and delivered a child with birth defects such as persistent pulmonary hypertension, heart valve problems, or other malformations, you should find an experienced personal injury lawyer who can file an antidepressant lawsuit on your behalf. d’Oliveira & Associates is working with some of the more experienced antidepressant lawyers in the country who will work to help you obtain an antidepressant settlement or an award. Feel free to contact our law offices anytime at 1-800-992-6878.

Links:

(i) FDA Public Health Advisory, July 2006. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm124348.htm
(ii) US News Article, June 2007. http://health.usnews.com/usnews/health/articles/070627/27antidepressant.htm
(iii) Bloomberg Report, July 2010. http://www.bloomberg.com/news/2010-07-20/glaxo-said-to-have-paid-1-billion-to-resolve-paxil-birth-defect-lawsuits.html

Read the full story at http://www.prweb.com/releases/2013/5/prweb10763916.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury
2. Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event
3. Water Entrepreneur Announces First Ever Personal Dry Eye Humidifier
4. Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries
5. Spring and The Woodlands Personal Training Centers Held Successful “Our Loss Their Gain” Clothing Drive to Help Local Women’s Center
6. Bedros Keuilian, Fitness Marketing Mastermind and Founder of PTPower.com, Reveals New Fitness Center Business Plan to Help Personal Trainers Wanting to Grow Their Fitness
7. Personal Injury Law Firm Helps New Bedford Man Recover $650,000 For Auto Accident Injuries
8. Atlanta Personal Injury Lawyer at Stokes & Kopitsky, P.A. Commends Plans to Make Streets Safer for Cyclists
9. Study supports alternative model for personality disorders in upcoming DSM-5
10. Brand id
11. Strategic Partners Hosts Monthly Workshop; Teaches Area Entrepreneurs To Own Their Personal Brand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Aerolib Healthcare Solutions ... Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, Utilization Review ... of Disease Specific Documentation Improvement. , The Aerolib Learning Management System is ...
(Date:1/19/2017)... ... 19, 2017 , ... With the cold weather here, many people will have to clear snow ... clearing large amounts of snow, but they can be dangerous when used incorrectly. That’s why ... Commission for the proper use of snow blowers:, , When removing ...
(Date:1/19/2017)... ... January 19, 2017 , ... WhoHaha , a digital media company ... Heart Association (AHA) to produce a three-part video series that uses humor to highlight ... of the launch of AHA’s Healthy For Good™ movement, which is designed to inspire ...
(Date:1/19/2017)... ... January 19, 2017 , ... WholeHealth is ... year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus will be present Saturday ... clinic’s leading recovery program. , “We know it’s easy to get carried ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... recently provided a new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health ... facility were used to facilitate a recapitalization of MedPro led by Harren Equity ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis instruments and consumables for the medical ... to discuss its financial results for the third quarter ... will be at 4:15 p.m. ET on Thursday, January ... the third quarter fiscal year 2017 after the market ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
(Date:1/19/2017)... 19, 2017 While various ... about reducing the FDA,s regulatory strictness as a ... medical drug industry, many of the leading biotech ... trials and development of advanced drug treatments and ... recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: